TC BioPharm Holdings PLC (TCBP)

NASDAQ
0.36
-0.04(-9.43%)
After Hours
0.39
+0.03(+7.37%)
- Real-time Data
  • Volume:
    337,556
  • Day's Range:
    0.36 - 0.41
  • 52 wk Range:
    0.33 - 3.50

TCBP Overview

Prev. Close
0.4
Day's Range
0.36-0.41
Revenue
-
Open
0.4
52 wk Range
0.33-3.5
EPS
-
Volume
337,556
Market Cap
15.23M
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
963,774
P/E Ratio
-
Beta
-
1-Year Change
-
Shares Outstanding
38,063,909
Next Earnings Date
-
What is your sentiment on TC BioPharm Holdings?
or
Market is currently closed. Voting is open during market hours.

TC BioPharm Holdings PLC News

TC BioPharm Holdings PLC Company Profile

TC BioPharm Holdings PLC Company Profile

Employees
76

TC Biopharm (Holdings) Plc, a clinical-stage biopharmaceutical company, focuses on developing immunotherapy products based on its allogeneic gamma delta T cell platform. Its product pipeline includes OmnImmune, an unmodified cell therapy used in the treatment of acute myeloid leukemia; and ImmuniStim, an unmodified cell therapy to treat COVID-19. The company was founded in 2013 and is headquartered in Motherwell, the United Kingdom.

Read More

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong SellStrong SellStrong SellStrong SellSell
Technical IndicatorsSellStrong SellStrong SellStrong SellNeutral
SummaryStrong SellStrong SellStrong SellStrong SellNeutral
  • this is a very good stock 👍
    1